Meghan M. Joly

723 total citations
14 papers, 337 citations indexed

About

Meghan M. Joly is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Meghan M. Joly has authored 14 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Meghan M. Joly's work include PI3K/AKT/mTOR signaling in cancer (4 papers), COVID-19 Clinical Research Studies (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Meghan M. Joly is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), COVID-19 Clinical Research Studies (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Meghan M. Joly collaborates with scholars based in United States, South Africa and Canada. Meghan M. Joly's co-authors include Rebecca S. Cook, Donna J. Hicks, Violeta Sánchez, Michelle M. Williams, Dana M. Brantley‐Sieders, Bayley A. Jones, William J. Muller, Christian D. Young, Dos D. Sarbassov and Mónica V. Estrada and has published in prestigious journals such as Circulation, Cancer Research and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Meghan M. Joly

12 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meghan M. Joly United States	10	222	72	62	32	30	14	337
Hon Yan Kelvin Yip Australia	7	177 0.8×	106 1.5×	56 0.9×	28 0.9×	28 0.9×	9	321
Sareena Singh United States	7	194 0.9×	90 1.3×	95 1.5×	16 0.5×	30 1.0×	10	332
Jesús García‐Cano Spain	10	179 0.8×	68 0.9×	53 0.9×	14 0.4×	35 1.2×	10	254
Faying Xu China	4	289 1.3×	105 1.5×	115 1.9×	21 0.7×	41 1.4×	6	391
Sheren Al-Obaidi Australia	7	190 0.9×	89 1.2×	39 0.6×	22 0.7×	19 0.6×	8	268
Alicja Przybyszewska-Podstawka Poland	10	281 1.3×	90 1.3×	105 1.7×	34 1.1×	30 1.0×	17	408
Peipei Nie China	8	277 1.2×	71 1.0×	163 2.6×	28 0.9×	35 1.2×	8	400
Graeme Benstead-Hume United Kingdom	8	270 1.2×	37 0.5×	87 1.4×	24 0.8×	25 0.8×	12	341
Yung-Chieh Chang Taiwan	10	343 1.5×	137 1.9×	76 1.2×	18 0.6×	52 1.7×	15	520

Countries citing papers authored by Meghan M. Joly

Since Specialization

Citations

This map shows the geographic impact of Meghan M. Joly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan M. Joly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan M. Joly more than expected).

Fields of papers citing papers by Meghan M. Joly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan M. Joly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan M. Joly. The network helps show where Meghan M. Joly may publish in the future.

Co-authorship network of co-authors of Meghan M. Joly

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan M. Joly. A scholar is included among the top collaborators of Meghan M. Joly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan M. Joly. Meghan M. Joly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schaich, Christopher L., Mark C. Chappell, Matthew S. Shotwell, et al.. (2025). The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(3). L405–L412.

Schaich, Christopher L., D. Clark Files, Matthew S. Shotwell, et al.. (2024). Abstract P130: Higher Circulating Angiotensin Converting Enzyme 2 (ACE2) and ACE2 to ACE Ratio Are Associated With Lower COVID-19 Mortality: A Mechanistic Substudy of the ACTIV-4 Host Tissue Trials. Circulation. 149(Suppl_1). 1 indexed citations

Jerome, Rebecca N, Meghan M. Joly, Jana K. Shirey-Rice, et al.. (2024). Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective. Translational Gastroenterology and Hepatology. 9. 2–2. 1 indexed citations

Joly, Meghan M., et al.. (2023). Taking AIM at serious illness: implementing an access to investigational medicines expanded access program. Frontiers in Medicine. 10. 1287449–1287449.

Cheng, Alex, Jakea Johnson, Nan Kennedy, et al.. (2022). Evaluating automated electronic case report form data entry from electronic health records. Journal of Clinical and Translational Science. 7(1). e29–e29. 10 indexed citations

Werfel, Thomas A., Donna J. Hicks, Bushra Rahman, et al.. (2020). Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study. Molecular Cancer Therapeutics. 19(12). 2454–2464. 15 indexed citations

Jerome, Rebecca N, Meghan M. Joly, Nan Kennedy, et al.. (2020). Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use. Drug Safety. 43(6). 567–582. 11 indexed citations

Pulley, Jill M., Jillian P. Rhoads, Rebecca N Jerome, et al.. (2019). Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data. The Annual Review of Pharmacology and Toxicology. 60(1). 333–352. 37 indexed citations

Werfel, Thomas A., Shan Wang, Meredith A. Jackson, et al.. (2018). Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. Cancer Research. 78(7). 1845–1858. 54 indexed citations

10.

Williams, Michelle M., Linus Lee, Thomas A. Werfel, et al.. (2018). Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell Death and Disease. 9(2). 21–21. 19 indexed citations

11.

Joly, Meghan M., Michelle M. Williams, Donna J. Hicks, et al.. (2017). Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Breast Cancer Research. 19(1). 74–74. 56 indexed citations

12.

Williams, Michelle M., David Vaught, Meghan M. Joly, et al.. (2017). ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation. Breast Cancer Research. 19(1). 105–105. 23 indexed citations

13.

Joly, Meghan M., Donna J. Hicks, Bayley A. Jones, et al.. (2016). Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2 -Amplified Breast Cancers. Cancer Research. 76(16). 4752–4764. 69 indexed citations

14.

Williams, Michelle M., Linus Lee, Donna J. Hicks, et al.. (2016). Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade. Molecular Cancer Research. 15(3). 259–268. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact